2018-2021年ST段抬高型心肌梗死患者的治疗时间与院内死亡率
该研究为横断面研究,基于Get With The Guidelines-冠状动脉疾病登记,纳入2018年第二季度至2021年第三季度648家医院的114 871例STEMI患者,分析治疗时间和院内死亡率。结果显示,经急救医疗服务转运的患者首次医疗接触至实验室激活≤20分钟、首次医疗接触至器械≤90分钟、自行来院患者到院至器械≤90分钟、转运患者door-in to door-out时间<30分钟及首诊医院到院至器械≤120分钟,均与调整后院内死亡率降低相关。然而,大多数季度未达到系统目标,需院际转运的患者延迟最严重,仅17%在120分钟内接受治疗。
要点
- 经急救医疗服务转运者,首次医疗接触至实验室激活≤20分钟较超时者院内死亡率3.6 vs 9.2,调整OR 0.54(95%CI 0.48-0.60)。
- 经急救医疗服务转运者,首次医疗接触至器械≤90分钟较超时者院内死亡率3.3 vs 12.1,调整OR 0.40(95%CI 0.36-0.44)。
- 自行来院者到院至器械≤90分钟较超时者院内死亡率1.8 vs 4.7,调整OR 0.47(95%CI 0.40-0.55)。
- 转运患者door-in to door-out时间<30分钟较≥30分钟者院内死亡率2.9 vs 6.4,调整OR 0.51(95%CI 0.32-0.78)。
- 需院际转运的患者延迟最严重,仅17%在120分钟内接受治疗,大多数季度未达到系统目标。
适用人群与场景
- 2018年第二季度至2021年第三季度在648家医院Get With The Guidelines-冠状动脉疾病登记中治疗的114 871例STEMI患者。
- 研究人群包括STEMI或STEMI等危症患者,中位年龄63岁(IQR 54-72),71%为男性,29%为女性。
诊断标准与关键阈值
- 系统目标:若首诊医院具备经皮冠状动脉介入治疗(PCI)能力,75%的患者在首次医疗接触后≤90分钟内接受治疗;若患者需转运至PCI capable医院,75%在≤120分钟内接受治疗。
研究设计与关键结果
- 研究设计:横断面研究,基于诊断登记,纳入114 871例STEMI患者,来自648家医院。
- 中位症状发作至PCI时间:经急救医疗服务至PCI capable医院者148分钟(IQR 111-226),自行来院者195分钟(IQR 127-349),院际转运者240分钟(IQR 166-402)。
- 经急救医疗服务转运者:首次医疗接触至实验室激活≤20分钟 vs 超时,院内死亡率3.6 vs 9.2,调整OR 0.54(95%CI 0.48-0.60);首次医疗接触至器械≤90分钟 vs 超时,院内死亡率3.3 vs 12.1,调整OR 0.40(95%CI 0.36-0.44)。
- 自行来院者:到院至器械≤90分钟 vs 超时,院内死亡率1.8 vs 4.7,调整OR 0.47(95%CI 0.40-0.55)。
- 转运患者:door-in to door-out时间<30分钟 vs ≥30分钟,院内死亡率2.9 vs 6.4,调整OR 0.51(95%CI 0.32-0.78);首诊医院到院至器械≤120分钟 vs 超时,院内死亡率4.3 vs 14.2,调整OR 0.44(95%CI 0.26-0.71)。
- 无论就诊方式如何,大多数季度未达到系统目标,需院际转运的患者系统表现延迟最严重,仅17%在≤120分钟内接受治疗。
证据类型、等级与局限
- 证据类型:横断面研究,基于美国国家登记。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于经急救医疗服务转运的STEMI患者,首次医疗接触至实验室激活≤20分钟和首次医疗接触至器械≤90分钟与较低的调整院内死亡率相关。
- 对于自行来院的STEMI患者,到院至器械≤90分钟与较低的调整院内死亡率相关。
- 对于需院际转运的STEMI患者,door-in to door-out时间<30分钟和首诊医院到院至器械≤120分钟与较低的调整院内死亡率相关。
指南或共识出处
- 美国国家指南推荐针对STEMI的具体治疗时间目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Recognizing the association between timely treatment and less myocardial injury for patients with ST-segment elevation myocardial infarction (STEMI), US national guidelines recommend specific treatment-time goals.
OBJECTIVE: To describe these process measures and outcomes for a recent cohort of patients.
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of a diagnosis-based registry between the second quarter of 2018 and the third quarter of 2021 for 114 871 patients with STEMI treated at 648 hospitals in the Get With The Guidelines-Coronary Artery Disease registry.
EXPOSURES: STEMI or STEMI equivalent.
MAIN OUTCOMES AND MEASURES: Treatment times, in-hospital mortality, and adherence to system goals (75% treated ≤90 minutes of first medical contact if the first hospital is percutaneous coronary intervention [PCI]-capable and ≤120 minutes if patients require transfer to a PCI-capable hospital).
RESULTS: In the study population, median age was 63 (IQR, 54-72) years, 71% were men, and 29% were women. Median time from symptom onset to PCI was 148 minutes (IQR, 111-226) for patients presenting to PCI-capable hospitals by emergency medical service, 195 minutes (IQR, 127-349) for patients walking in, and 240 minutes (IQR, 166-402) for patients transferred from another hospital. Adjusted in-hospital mortality was lower for those treated within target times vs beyond time goals for patients transported via emergency medical services (first medical contact to laboratory activation ≤20 minutes [in-hospital mortality, 3.6 vs 9.2] adjusted OR, 0.54 [95% CI, 0.48-0.60], and first medical contact to device ≤90 minutes [in-hospital mortality, 3.3 vs 12.1] adjusted OR, 0.40 [95% CI, 0.36-0.44]), walk-in patients (hospital arrival to device ≤90 minutes [in-hospital mortality, 1.8 vs 4.7] adjusted OR, 0.47 [95% CI, 0.40-0.55]), and transferred patients (door-in to door-out time <30 minutes [in-hospital mortality, 2.9 vs 6.4] adjusted OR, 0.51 [95% CI, 0.32-0.78], and first hospital arrival to device ≤120 minutes [in-hospital mortality, 4.3 vs 14.2] adjusted OR, 0.44 [95% CI, 0.26-0.71]). Regardless of mode of presentation, system goals were not met in most quarters, with the most delayed system performance among patients requiring interhospital transfer (17% treated ≤120 minutes).
CONCLUSIONS AND RELEVANCE: This study of patients with STEMI included in a US national registry provides information on changes in process and outcomes between 2018 and 2021.
参考来源
- Jollis JG, Granger CB, Zègre-Hemsey JK, et al. Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021. JAMA. 2022. PMID: 36335474. doi:10.1001/jama.2022.20149
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。